AdBlock rilevato
We have detected an active AdBlocker!

Please disable your AdBlocker or add this site to your exceptions.

Our advertising is not intrusive and will not disturb you.
It allows the site to sustain itself, grow, and provide you with new content.

You will not be able to access the content as long as AdBlocker remains active.
After disabling it, this window will close automatically.

Sfondo Header
L'angolo del dottorino
Search the site... Advanced search

Myocarditis: Primary and Directly Correlated Forms

Infectious Myocarditis

Infectious myocarditis is caused by pathogens that directly invade the myocardium or trigger a harmful immune response. The severity of the clinical picture depends on both the aggressiveness of the pathogen and the host's immune response.

Viral Myocarditis

Viral myocarditis is the most common form and often presents after a systemic viral infection. The viruses involved are:

Distinctive feature: many viral forms present an initial flu-like syndrome, followed by cardiac symptoms such as chest pain, palpitations, or dyspnea.

Bacterial Myocarditis

Bacterial myocarditis mainly arises from bacteremia with cardiac dissemination of the pathogen. The most frequently involved organisms include:

Distinctive feature: bacterial myocarditis is more frequently suppurative, with a risk of microabscess formation or localized fibrosis.

Fungal Myocarditis

A rare form, typically associated with immunosuppression. The main etiologies include:

Distinctive feature: often associated with multiorgan involvement and signs of septic embolization.

Parasitic Myocarditis

Occurs predominantly in endemic areas or immunocompromised patients. The main cause is:

Distinctive feature: the chronic form may result in apical ventricular aneurysms and AV conduction disturbances.


Non-Infectious Myocarditis

Non-infectious myocarditis results from immunological or toxic reactions. Myocardial injury is predominantly mediated by inflammation rather than by direct pathogen invasion.

Eosinophilic Myocarditis

This form is characterized by eosinophilic myocardial infiltration, detectable through endomyocardial biopsy. It may result from various conditions:

Distinctive feature: may present with acute heart failure and systemic manifestations such as rash and marked eosinophilia.

Toxic Myocarditis

Caused by exposure to cardiotoxic substances with variable mechanisms of injury. The main causes include:

Distinctive feature: toxic myocarditis may present with dose-dependent cardiac injury or idiosyncratic reactions, often with parallel systemic involvement (hepatotoxicity, neurotoxicity).

Idiopathic Myocarditis

A diagnosis of exclusion, when no specific cause is identified. Some forms may have an as yet unidentified autoimmune basis.

Distinctive feature: may present with rapidly progressive ventricular dysfunction and partial response to steroids.


Complications of Myocarditis

Myocarditis can lead to cardiovascular complications of varying severity. The main ones include:

Summary Table of Myocarditis

Type of Myocarditis Etiology Distinctive Features Typical Clinical Manifestations Complications
Viral Coxsackievirus, Parvovirus B19, Adenovirus, SARS-CoV-2 Fever, initial flu-like syndrome Chest pain, dyspnea, palpitations Heart failure, arrhythmias
Bacterial Staphylococcus aureus, Borrelia burgdorferi (Lyme), TB Frequently suppurative, microabscesses High fever, septic shock, signs of systemic infection Septic shock, AV blocks
Fungal Candida spp., Aspergillus spp. Associated with immunosuppression Signs of sepsis, septic embolization Systemic emboli, endocarditis
Parasitic Trypanosoma cruzi (Chagas) Chronic evolution with fibrosis AV conduction disturbances, ventricular aneurysms Dilated cardiomyopathy
Eosinophilic Drugs, hypereosinophilic syndrome Eosinophilic infiltrates, skin rash Acute heart failure Myocardial fibrosis
Toxic Drugs (chemotherapeutic agents, immunotherapies), drugs of abuse, alcohol Dose-dependent myocardial injury Ventricular dysfunction, arrhythmias Irreversible heart failure
Idiopathic Unknown (likely autoimmune basis) Diagnosis of exclusion Ventricular dysfunction, variable progression Dilated cardiomyopathy
    References
  1. Caforio et al. Myocarditis: current clinical and diagnostic approaches. European Heart Journal. 2021; 42(36): 3873-3884.
  2. Ammirati et al. Acute and chronic myocarditis: diagnosis and management. JAMA Cardiology. 2020; 5(5): 543-556.
  3. Friedrich et al. Cardiac MRI in myocarditis. Journal of the American College of Cardiology. 2019; 73(12): 1456-1472.
  4. Mavrogeni et al. Imaging modalities for myocarditis. Radiology. 2021; 299(3): 523-534.
  5. Yilmaz et al. Diagnostic and prognostic implications of biopsy in myocarditis. Cardiology. 2020; 145(2): 159-170.
  6. Kindermann et al. Update on myocarditis. Journal of the American College of Cardiology. 2012; 59(9): 779-792.
  7. Cooper LT Jr. Myocarditis. New England Journal of Medicine. 2009; 360(15): 1526-1538.
  8. Escher et al. Emerging therapies for myocarditis. Heart Failure Reviews. 2020; 25(5): 735-745.
  9. Maisch et al. Myocarditis: current trends in diagnosis and treatment. Cardiovascular Diagnosis and Therapy. 2017; 7(4): 373-388.
  10. Pollack et al. Viral myocarditis—diagnosis, treatment options, and current controversies. Nature Reviews Cardiology. 2015; 12(11): 670-680.